AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3773677 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclined terrain running (IP) 4 times/wk for 35 min/session at 65 to 85% of maximal aerobic power for 12 weeks
Number of subjects: 22
Study 3773677 — intervention group
Group type: COMPARATOR
Intervention: Horizontal protocol (HP)
Number of subjects: 22
Study 29534382 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guided quadratus lumborum block with 30 ml 0.33% ropivacaine
Number of subjects: 60
Study 27557406 — intervention group
Group type: EXPERIMENTAL
Intervention: Jump training group (JG)
Number of subjects: 63
Study 27557406 — intervention group
Group type: EXPERIMENTAL
Intervention: Jump training group plus haltere type handheld loading (LJG)
Number of subjects: 63
Study 27557406 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 63
Study 24737045 — intervention group
Group type: EXPERIMENTAL
Intervention: Different-system condition
Number of subjects: 0
Study 24737045 — intervention group
Group type: COMPARATOR
Intervention: Same-system condition
Number of subjects: 0
Study 24737045 — intervention group
Group type: EXPERIMENTAL
Intervention: Different-system condition (replicated in Experiment 2)
Number of subjects: 0
Study 23760393 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (16 sessions)
Number of subjects: 65
Study 23760393 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram oxalate (10-20 mg/d)
Number of subjects: 65
Study 20220589 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 131
Study 20220589 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 18171292 — intervention group
Group type: EXPERIMENTAL
Intervention: TDF+PI/r
Number of subjects: 146
Study 18171292 — intervention group
Group type: COMPARATOR
Intervention: TDF+NNRTI
Number of subjects: 146
Study 18171292 — intervention group
Group type: COMPARATOR
Intervention: non-TDF-containing regimen
Number of subjects: 146
Study 16921080 — intervention group
Group type: EXPERIMENTAL
Intervention: Dedicated A&E psychiatric nurse service (4 experienced community psychiatric nurses)
Number of subjects: 100
Study 12746632 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 8
Study 12746632 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 10816183 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone (maximal dose, 600 mg per day)
Number of subjects: 681
Study 10816183 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral-analysis system of psychotherapy (16 to 20 sessions)
Number of subjects: 681
Study 10816183 — intervention group
Group type: COMPARATOR
Intervention: Combined treatment (Nefazodone + Cognitive behavioral-analysis system of psychotherapy)
Number of subjects: 681
Study 10816183 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 681
Study 10816183 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral-analysis system of psychotherapy
Number of subjects: 681
Study 8643759 — intervention group
Group type: EXPERIMENTAL
Intervention: LLPDD subjects
Number of subjects: 30
Study 8643759 — intervention group
Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 30
Study 1574663 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual model performing an underhand modified softball pitch with verbal performance cues added at the second, third, or fourth trial block.
Number of subjects: 36
Study 1574663 — intervention group
Group type: COMPARATOR
Intervention: Visual model performing an underhand modified softball pitch without verbal performance cues.
Number of subjects: 36
Study 6148473 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate
Number of subjects: 9
Study 6148473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 31589587 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP+aPDT (using a low-power laser application Photon Lase III with operational parameters of 660 nm and 100 mW for 15 sec)
Number of subjects: 54
Study 31589587 — intervention group
Group type: COMPARATOR
Intervention: SRP (control group)
Number of subjects: 54
Study 29300289 — intervention group
Group type: EXPERIMENTAL
Intervention: Clean stoma catheterization
Number of subjects: 27
Study 29300289 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine dripping from the stoma
Number of subjects: 27
Study 29300289 — intervention group
Group type: EXPERIMENTAL
Intervention: Clean urostomy pouch
Number of subjects: 27
Study 27631562 — intervention group
Group type: EXPERIMENTAL
Intervention: CE 0.45 mg/BZA 20 mg
Number of subjects: 60
Study 27631562 — intervention group
Group type: EXPERIMENTAL
Intervention: CE 0.625 mg/BZA 20 mg
Number of subjects: 60
Study 27631562 — intervention group
Group type: EXPERIMENTAL
Intervention: CE/BZA
Number of subjects: 60
Study 24722494 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 637
Study 24722494 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 637
Study 24722494 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 637
Study 22737979 — intervention group
Group type: EXPERIMENTAL
Intervention: Best practices primary care plus home-based occupational therapy (24 sessions over 2 years)
Number of subjects: 180
Study 22737979 — intervention group
Group type: COMPARATOR
Intervention: Best practices primary care
Number of subjects: 180
Study 22737979 — intervention group
Group type: EXPERIMENTAL
Intervention: Best practices primary care plus home-based occupational therapy
Number of subjects: 180
Study 20736456 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoblastic (IB) morphology
Number of subjects: 949
Study 20736456 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunohistochemical markers (CD5, CD10, BCL2, BCL6, HLA-DR, IRF4/MUM1, Ki-67)
Number of subjects: 949
Study 20736456 — intervention group
Group type: EXPERIMENTAL
Intervention: Hans algorithm using CD10, BCL6, and IRF4/MUM1
Number of subjects: 949
Study 18539675 — intervention group
Group type: EXPERIMENTAL
Intervention: Lengthening of the flexor hallucis longus and flexor digitorum longus tendons
Number of subjects: 13
Study 18539675 — intervention group
Group type: COMPARATOR
Intervention: Simple decompression
Number of subjects: 13
Study 15989908 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective primary stent (n = 124)
Number of subjects: 246
Study 12460397 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized behavioural intervention implemented in 12 communities (arms A and B) through community-based education, meetings, and information leaflets.
Number of subjects: 15000
Study 12460397 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved STD management through government and private health units (arm B).
Number of subjects: 15000
Study 12460397 — intervention group
Group type: COMPARATOR
Intervention: Routine government health services (arm C).
Number of subjects: 15000
Study 9845803 — intervention group
Group type: EXPERIMENTAL
Intervention: ITF 296 (oral solution)
Number of subjects: 11
Study 9845803 — intervention group
Group type: EXPERIMENTAL
Intervention: ITF 296 (immediate-release tablet)
Number of subjects: 11
Study 9845803 — intervention group
Group type: EXPERIMENTAL
Intervention: ITF 296 (intravenous infusion)
Number of subjects: 11
Study 9845803 — intervention group
Group type: EXPERIMENTAL
Intervention: ITF 296 (oral administration)
Number of subjects: 11
Study 7482015 — intervention group
Group type: EXPERIMENTAL
Intervention: Back pain care episodes
Number of subjects: 3105
Study 7482015 — intervention group
Group type: EXPERIMENTAL
Intervention: Sociodemographic and health status variables
Number of subjects: 3105
Study 2158869 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin injection
Number of subjects: 6
Study 2158869 — intervention group
Group type: COMPARATOR
Intervention: Saline injection (Control)
Number of subjects: 6
Study 338412 — intervention group
Group type: EXPERIMENTAL
Intervention: Trasylol administered before and after ERCP
Number of subjects: 61
Study 31953483 — intervention group
Group type: EXPERIMENTAL
Intervention: TP-fusion
Number of subjects: 77
Study 31953483 — intervention group
Group type: COMPARATOR
Intervention: TR-fusion
Number of subjects: 77
Study 30958014 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 318
Study 30958014 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (FLX)
Number of subjects: 318
Study 30958014 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (COMB)
Number of subjects: 318
Study 30958014 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 318
Study 28467293 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab 10 mg/kg intravenous treatment (concurrent cohort)
Number of subjects: 79
Study 28467293 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccination (pre-belimumab cohort)
Number of subjects: 79
Study 26077267 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring of oral anticoagulation therapy (OAT)
Number of subjects: 296
Study 23632782 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-level drill guide template for pedicle screw placement
Number of subjects: 20
Study 23632782 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopy-supervised free-hand technique
Number of subjects: 20
Study 21768322 — intervention group
Group type: EXPERIMENTAL
Intervention: Very preterm children
Number of subjects: 363
Study 21768322 — intervention group
Group type: COMPARATOR
Intervention: Term children
Number of subjects: 363
Study 19630546 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Treatment (ET) walking intervention
Number of subjects: 278
Study 19630546 — intervention group
Group type: COMPARATOR
Intervention: Minimal Treatment (MT) walking intervention
Number of subjects: 278
Study 16991061 — intervention group
Group type: EXPERIMENTAL
Intervention: Total hip replacement
Number of subjects: 115
Study 16991061 — intervention group
Group type: COMPARATOR
Intervention: Total knee replacement
Number of subjects: 115
Study 15499150 — intervention group
Group type: EXPERIMENTAL
Intervention: PIPP (Premature Infant Pain Profile)
Number of subjects: 51
Study 15499150 — intervention group
Group type: EXPERIMENTAL
Intervention: CRIES (Crying, Requires oxygen, Increased vital signs, Expression, Sleepless)
Number of subjects: 51
Study 15499150 — intervention group
Group type: COMPARATOR
Intervention: Visual Analogue Scale (VAS)
Number of subjects: 51
Study 10690871 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 500 microg/day for 2 months, then 200 microg/day thereafter
Number of subjects: 75
Study 10690871 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) 800 microg/day for 2 months, then 400 microg/day thereafter
Number of subjects: 75
Study 10690871 — intervention group
Group type: COMPARATOR
Intervention: Cromone (CROM)
Number of subjects: 75
Study 10179578 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural network analysis of biochemical markers (myoglobin, CK-MB, troponin-T) for early diagnosis/exclusion of AMI.
Number of subjects: 88
Study 8383012 — intervention group
Group type: EXPERIMENTAL
Intervention: pH adjusted mepivacaine (4 ml sodium bicarbonate added, final pH 7.31)
Number of subjects: 39
Study 8383012 — intervention group
Group type: COMPARATOR
Intervention: Control group (4 ml saline added, final pH 5.6)
Number of subjects: 39
Study 3533546 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine (Mexitil‐Perlongets), 360 mg b.i.d.
Number of subjects: 630
Study 3533546 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 630
Study 31499515 — intervention group
Group type: EXPERIMENTAL
Intervention: SVHD group
Number of subjects: 25
Study 31499515 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 25
Study 29550362 — intervention group
Group type: EXPERIMENTAL
Intervention: MD with aPDT (test group)
Number of subjects: 38
Study 29550362 — intervention group
Group type: COMPARATOR
Intervention: MD only (control group)
Number of subjects: 38
Study 27707818 — intervention group
Group type: EXPERIMENTAL
Intervention: MAG-enriched oil (500 mg EPA/day and 300 mg DHA/day)
Number of subjects: 45
Study 27707818 — intervention group
Group type: EXPERIMENTAL
Intervention: MAG-enriched oil
Number of subjects: 45
Study 27707818 — intervention group
Group type: COMPARATOR
Intervention: TAG
Number of subjects: 45
Study 24949605 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose PMC (PMC4/0)
Number of subjects: 600
Study 24949605 — intervention group
Group type: COMPARATOR
Intervention: Single dose PEG (PEG4/0)
Number of subjects: 600
Study 24949605 — intervention group
Group type: EXPERIMENTAL
Intervention: Split dose PMC (PMC2/2)
Number of subjects: 600
Study 24949605 — intervention group
Group type: COMPARATOR
Intervention: Split dose PEG (PEG3/1)
Number of subjects: 600
Study 24949605 — intervention group
Group type: EXPERIMENTAL
Intervention: PMC (any regimen)
Number of subjects: 600
Study 24949605 — intervention group
Group type: COMPARATOR
Intervention: 4L PEG
Number of subjects: 600
Study 24949605 — intervention group
Group type: EXPERIMENTAL
Intervention: Split PMC dose
Number of subjects: 600
Study 22337905 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX; 1 mg)
Number of subjects: 21
Study 22337905 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 20167180 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir, dosed once daily
Number of subjects: 29
Study 20167180 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine, dosed once daily
Number of subjects: 29
Study 19046729 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone plus ciprofloxacin
Number of subjects: 95
Study 19046729 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime plus amikacin
Number of subjects: 95
Study 15818325 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic reduced-intensity hematopoietic stem cell transplantation (RIST)
Number of subjects: 7
Study 12578294 — intervention group
Group type: EXPERIMENTAL
Intervention: TPN with 1 IU ml(‐1) of heparin (n = 35)
Number of subjects: 66
Study 12578294 — intervention group
Group type: COMPARATOR
Intervention: No heparin (n = 31)
Number of subjects: 66
Study 10615932 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy and 5-fluorouracil
Number of subjects: 218
Study 10615932 — intervention group
Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 218
Study 8623079 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumpectomy with radiation
Number of subjects: 4
Study 8623079 — intervention group
Group type: COMPARATOR
Intervention: Lumpectomy alone
Number of subjects: 4
Study 1747614 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention schools (n=228)
Number of subjects: 451
Study 1747614 — intervention group
Group type: COMPARATOR
Intervention: Control schools (n=223)
Number of subjects: 451
Study 1747614 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 451
Study 7188378 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.0 mg zopiclone
Number of subjects: 6
Study 7188378 — intervention group
Group type: EXPERIMENTAL
Intervention: 10.0 mg zopiclone
Number of subjects: 6
Study 7188378 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg zopiclone
Number of subjects: 6
Study 7188378 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 30063996 — intervention group
Group type: EXPERIMENTAL
Intervention: Defibrillation Testing (DT)
Number of subjects: 251
Study 30063996 — intervention group
Group type: COMPARATOR
Intervention: No Defibrillation Testing (no DT)
Number of subjects: 251
Study 30063996 — intervention group
Group type: EXPERIMENTAL
Intervention: Both DT and no DT
Number of subjects: 251
Study 28434387 — intervention group
Group type: EXPERIMENTAL
Intervention: bsIFX
Number of subjects: 0
Study 28434387 — intervention group
Group type: EXPERIMENTAL
Intervention: bsIFX-ADA
Number of subjects: 0
Study 28434387 — intervention group
Group type: EXPERIMENTAL
Intervention: bsIFX-ADA-VEDO
Number of subjects: 0
Study 25385024 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Oriented Recovery Enhancement (MORE) for 8 weeks
Number of subjects: 29
Study 25385024 — intervention group
Group type: COMPARATOR
Intervention: Support group control condition for 8 weeks
Number of subjects: 29
Study 25385024 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Oriented Recovery Enhancement (MORE)
Number of subjects: 29
Study 24296479 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBMP-2
Number of subjects: 197
Study 24296479 — intervention group
Group type: COMPARATOR
Intervention: iliac crest autograft
Number of subjects: 197
Study 21710405 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic medication (various neuroleptic medications)
Number of subjects: 42
Study 21710405 — intervention group
Group type: COMPARATOR
Intervention: Neuroleptic wash-out (baseline)
Number of subjects: 42
Study 21710405 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 42
Study 19526753 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Astragalus Recipe (CAR)
Number of subjects: 60
Study 19526753 — intervention group
Group type: COMPARATOR
Intervention: Prednisone (Control)
Number of subjects: 60
Study 19526753 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 16286908 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 0
Study 16286908 — intervention group
Group type: EXPERIMENTAL
Intervention: Future studies
Number of subjects: 0
Study 12117080 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide administered by Turbuhaler (DPI)
Number of subjects: 0
Study 12117080 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 0
Study 12117080 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide therapy
Number of subjects: 0
Study 12117080 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmicort Respules (nebulized formulation)
Number of subjects: 0
Study 10606369 — intervention group
Group type: EXPERIMENTAL
Intervention: Mab 3E10
Number of subjects: 9
Study 8960734 — intervention group
Group type: EXPERIMENTAL
Intervention: Lee Silverman Voice Treatment (LSVT)
Number of subjects: 35
Study 8960734 — intervention group
Group type: COMPARATOR
Intervention: Placebo (respiration) treatment
Number of subjects: 35
Study 1762311 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetate dialysate (Ac)
Number of subjects: 30
Study 1762311 — intervention group
Group type: COMPARATOR
Intervention: Acetate-free dialysate (Ac-free)
Number of subjects: 30
Study 6122057 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ketoconazole
Number of subjects: 72
Study 6122057 — intervention group
Group type: COMPARATOR
Intervention: Oral amphotericin B and nystatin
Number of subjects: 72
Study 31703023 — intervention group
Group type: EXPERIMENTAL
Intervention: CLU (4 sets × (2 × 5) repetitions, 30‐s intraset rest, 90‐s interset rest)
Number of subjects: 8
Study 31703023 — intervention group
Group type: COMPARATOR
Intervention: TRD (4 sets × 10 repetitions, 120‐s interset rest)
Number of subjects: 8
Study 30980006 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone application and movement sensor toothbrushing attachment
Number of subjects: 108
Study 30980006 — intervention group
Group type: COMPARATOR
Intervention: Control group (no smartphone device or toothbrush attachment)
Number of subjects: 108
Study 27574900 — intervention group
Group type: EXPERIMENTAL
Intervention: Type I - suprapubic incision surgery without laparoscopic support
Number of subjects: 43
Study 27574900 — intervention group
Group type: EXPERIMENTAL
Intervention: Type II - suprapubic incision surgery with laparoscopic support but without CO2 inflation
Number of subjects: 43
Study 27574900 — intervention group
Group type: EXPERIMENTAL
Intervention: Type III - suprapubic incision surgery with laparoscopic support and CO2 inflation
Number of subjects: 43
Study 25732163 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib 37.5 mg per day until progression
Number of subjects: 144
Study 25732163 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 25732163 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib after cross-over
Number of subjects: 144
Study 25714213 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 200
Study 25714213 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 200
Study 22865498 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.85 g/day eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) (low dose)
Number of subjects: 26
Study 22865498 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.4 g/day EPA + DHA (high dose)
Number of subjects: 26
Study 22865498 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 19523539 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding promotion interventions
Number of subjects: 0
Study 19523539 — intervention group
Group type: EXPERIMENTAL
Intervention: Research staff assistance
Number of subjects: 0
Study 17472824 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial preparation of TMP/SMX 40/200 mg per 5-ml, oral suspension
Number of subjects: 24
Study 17472824 — intervention group
Group type: COMPARATOR
Intervention: Reference preparation of TMP/SMX 40/200 mg per 5-ml, oral suspension
Number of subjects: 24
Study 14962965 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate 6 week self management programme based on pool exercises and education (n = 84)
Number of subjects: 164
Study 14962965 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group (n = 80)
Number of subjects: 164
Study 12691207 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA
Number of subjects: 0
Study 12691207 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9590144 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) given as 200 microg/m2/d SC starting one day after HD C/T until neutrophil recovery
Number of subjects: 17
Study 9590144 — intervention group
Group type: COMPARATOR
Intervention: High-dose cytarabine-containing chemotherapy (HD C/T) without G-CSF
Number of subjects: 17
Study 9590144 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF)
Number of subjects: 17
Study 7699487 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Depression Screen (SDS) for Major Depressive Disorder (MDD)
Number of subjects: 221